glp-1 therapies GLP-1-based for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Designing GLP-1 delivery: structural perspectives
Description
PMC Alharbi SH, et al
WHAT AREAS CAN BE TREATED WITH SOFWAVE
[DOI] [PubMed] [Google Scholar] 119.Aronne LJ, Sattar N, Horn DB, et al
Examples include: Semaglutide (Ozempic and Wegovy) Liraglutide (Saxenda and Victoza) Dulaglutide (Trulicity) These drugs: Help the body release insulin, but when blood sugar levels go up Lower glucagon levels to stop extra glucose from being made Slow down how fast the stomach empties so you feel full longer Curb hunger, which makes it easier to eat fewer calories When used with supervision, GLP-1 drugs like semaglutide may help people lose weight and manage metabolic health
Probiticos y prebiticos han ganado atencin por su capacidad de modular el microbioma intestinal, lo cual podra influir indirectamente en la secrecin de GLP-1
SECTION ON OBESITY
